Histakind-M Tablet is a prescription combination medicine containing montelukast 10 mg and fexofenadine 120 mg. It is primarily used to manage allergy symptoms such as sneezing, runny or stuffy nose, nasal congestion, itching, and watery eyes. Current product references identify this formulation as an anti-allergic combination marketed by Mankind Pharmaceuticals.

Rather than simply describing this medicine as something that “cures” allergies, it is more accurate to say that it helps control and relieve allergy symptoms. Allergic rhinitis can occur when the immune system reacts to substances such as pollen, dust mites, mold, or animal dander. The resulting release of inflammatory chemicals can cause repeated sneezing, nasal irritation, congestion, and watery or itchy eyes. Histakind-M Tablet combines two medicines that act through different pathways to help control these symptoms.

Composition of Histakind-M Tablet

Each tablet contains two active ingredients: fexofenadine 120 mg and montelukast 10 mg. Fexofenadine belongs to the antihistamine class and blocks histamine, a chemical involved in many allergy symptoms. Montelukast belongs to the leukotriene receptor antagonist class and blocks leukotrienes, inflammatory chemicals that contribute to swelling and mucus production in the airways and nasal passages.

This dual-action approach can be useful when a healthcare professional determines that both pathways contribute to a patient’s symptoms. However, patients should not assume that combining medicines is automatically better than using a single allergy treatment. A clinician should determine whether this prescription is appropriate.

Uses and Benefits

Doctors may prescribe Histakind-M Tablet for symptoms associated with allergic rhinitis, including seasonal or persistent allergy symptoms. These may include a runny nose, sneezing, nasal blockage, itchy nose, watery eyes, and congestion. Product information also describes its use in managing allergy-related respiratory symptoms.

The fexofenadine component helps reduce histamine-mediated symptoms such as sneezing, itching, and watery eyes. The montelukast component reduces the effects of leukotrienes that can contribute to inflammation and mucus production. Together, these effects can make allergy symptoms easier to manage when the medicine is appropriately prescribed.

Patients should understand that Histakind-M Tablet does not remove the underlying cause of an allergy. Avoiding known triggers remains an important part of allergy management. Keeping indoor spaces clean, reducing exposure to dust and pollen, and following an individualized allergy-management plan can complement medication treatment.

How to Take Histakind-M Tablet

Take Histakind-M Tablet exactly as directed by your healthcare professional. Available product information states that it can generally be taken with or without food, but you should follow the specific instructions on your prescription. Swallow the tablet whole with water rather than crushing or chewing it.

Do not increase the dose because your symptoms have not improved quickly. Taking more medicine does not necessarily provide faster relief and may increase the likelihood of adverse effects.

Fexofenadine should be taken with water rather than fruit juice. FDA labeling notes that apple, orange, and grapefruit juices can reduce fexofenadine exposure. Aluminum- or magnesium-containing antacids should also not be taken at the same time without appropriate professional guidance.

Possible Side Effects

Some people taking Histakind-M Tablet may experience headache, dizziness, drowsiness, nausea, vomiting, diarrhea, skin rash, or flu-like symptoms. These effects are not experienced by everyone, and many are mild and temporary.

Seek medical advice if side effects become persistent, severe, or concerning. Stop and seek prompt professional guidance for signs of a serious allergic reaction, such as significant facial or throat swelling or difficulty breathing.

Because this medicine contains montelukast, patients should pay particular attention to changes in mood or behavior. The U.S. FDA requires a boxed warning for montelukast because serious neuropsychiatric events, including suicidal thoughts or actions, have been reported. Patients should contact a healthcare professional immediately if new or worsening behavioral or mood symptoms occur.

Important Safety Information

Histakind-M Tablet should be used only under appropriate medical supervision. Tell your doctor about all prescription medicines, nonprescription medicines, supplements, and herbal products you use.

Discuss treatment with your healthcare professional if you have kidney or liver problems, are pregnant or planning pregnancy, or are breastfeeding. Product information specifically recommends caution in patients with kidney disease because dose adjustment may sometimes be necessary.

Do not use this medicine if you have previously experienced an allergic reaction to fexofenadine, montelukast, or any component of the formulation.

The medicine may cause dizziness or sleepiness in some individuals. Until you know how it affects you, use caution when driving or operating machinery. Alcohol may worsen drowsiness in susceptible individuals.

Importantly, Histakind-M Tablet should not be considered a rescue treatment for a sudden asthma attack. Patients with asthma should keep their prescribed quick-relief medication available and follow their asthma action plan.

Montelukast and Allergic Rhinitis: A Key FDA Warning

For U.S. patients, montelukast requires special consideration. The FDA advises that montelukast generally should be reserved for allergic rhinitis when alternative treatments have not worked adequately or cannot be tolerated because of the risk of serious mental health side effects.

This does not mean every patient will experience such effects. However, patients and caregivers should understand the warning before treatment. Report unusual nightmares, agitation, depression, anxiety, hallucinations, sleep disturbances, unusual behavior, or suicidal thoughts to a healthcare professional immediately.

Storage

Store Histakind-M Tablet according to the instructions supplied with the product. One current product reference recommends storage below 30°C and protection from inappropriate environmental conditions. Keep the tablets in their original packaging and away from children.

Do not use tablets after their expiration date, and ask a pharmacist about appropriate disposal of unused medication.

Frequently Asked Questions

What is Histakind-M Tablet used for?

Histakind-M Tablet is used to manage allergy symptoms such as sneezing, runny or stuffy nose, nasal congestion, itching, and watery eyes.

What does Histakind-M Tablet contain?

It contains fexofenadine 120 mg and montelukast 10 mg.

Can I take Histakind-M Tablet with food?

Product information indicates that it may be taken with or without food. Follow your prescriber’s specific instructions.

Can Histakind-M Tablet treat a sudden asthma attack?

No. Montelukast-containing products are not rescue medicines for an acute asthma attack. Follow your clinician’s asthma action plan and use your prescribed rescue medication when required.

Does Histakind-M Tablet cause drowsiness?

Some people may experience dizziness or drowsiness. Avoid driving or activities requiring full concentration until you know how the medicine affects you.